WO2011009114A3 - Methods and kits used in assessing cancer risk - Google Patents
Methods and kits used in assessing cancer risk Download PDFInfo
- Publication number
- WO2011009114A3 WO2011009114A3 PCT/US2010/042400 US2010042400W WO2011009114A3 WO 2011009114 A3 WO2011009114 A3 WO 2011009114A3 US 2010042400 W US2010042400 W US 2010042400W WO 2011009114 A3 WO2011009114 A3 WO 2011009114A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- cancer risk
- kits used
- assessing cancer
- assessing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10800657A EP2454388A2 (en) | 2009-07-17 | 2010-07-19 | Methods and kits used in assessing cancer risk |
AU2010273938A AU2010273938A1 (en) | 2009-07-17 | 2010-07-19 | Methods and kits used in assessing cancer risk |
KR1020127004297A KR20120089838A (en) | 2009-07-17 | 2010-07-19 | Methods and kits used in assessing cancer risk |
CA2768475A CA2768475A1 (en) | 2009-07-17 | 2010-07-19 | Methods and kits used in assessing cancer risk |
JP2012520834A JP2013507904A (en) | 2009-07-17 | 2010-07-19 | Method and kit for use in cancer risk assessment |
US13/384,567 US20120289416A1 (en) | 2009-07-17 | 2010-07-19 | Methods and kits used in assessing cancer risk |
IL217565A IL217565A0 (en) | 2009-07-17 | 2012-01-16 | Methods and kits used in assessing cancer risk |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22666609P | 2009-07-17 | 2009-07-17 | |
US61/226,666 | 2009-07-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011009114A2 WO2011009114A2 (en) | 2011-01-20 |
WO2011009114A3 true WO2011009114A3 (en) | 2014-03-20 |
Family
ID=43450263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/042400 WO2011009114A2 (en) | 2009-07-17 | 2010-07-19 | Methods and kits used in assessing cancer risk |
Country Status (8)
Country | Link |
---|---|
US (1) | US20120289416A1 (en) |
EP (1) | EP2454388A2 (en) |
JP (1) | JP2013507904A (en) |
KR (1) | KR20120089838A (en) |
AU (1) | AU2010273938A1 (en) |
CA (1) | CA2768475A1 (en) |
IL (1) | IL217565A0 (en) |
WO (1) | WO2011009114A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015124607A1 (en) * | 2014-02-18 | 2015-08-27 | Institut De Recerca Biomèdica De Lleida Fundació Doctor Pifarré | Method to predict risk of recurrence in endometrial carcinoma |
CA2975737A1 (en) * | 2015-02-06 | 2016-08-11 | Quest Diagnostics Investments Llc | Compositions and methods for determining endometrial cancer prognosis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060234347A1 (en) * | 2005-04-13 | 2006-10-19 | Harding Thomas C | Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
US20070083334A1 (en) * | 2001-09-14 | 2007-04-12 | Compugen Ltd. | Methods and systems for annotating biomolecular sequences |
WO2008118877A2 (en) * | 2007-03-23 | 2008-10-02 | The Translational Genomics Research Institute | Method of diagnosing, classifying and treating endometrial cancer and precancer |
US20090192133A1 (en) * | 2008-01-08 | 2009-07-30 | Horton William A | Treatment for achondroplasia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101472600B1 (en) * | 2006-08-28 | 2014-12-15 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Antitumor agent for undifferentiated gastric cancer |
WO2011115937A1 (en) * | 2010-03-14 | 2011-09-22 | The Translational Genomics Research Institute | Methods of determining susceptibility of tumors to tyrosine kinase inhibitors |
-
2010
- 2010-07-19 KR KR1020127004297A patent/KR20120089838A/en not_active Application Discontinuation
- 2010-07-19 JP JP2012520834A patent/JP2013507904A/en active Pending
- 2010-07-19 WO PCT/US2010/042400 patent/WO2011009114A2/en active Application Filing
- 2010-07-19 AU AU2010273938A patent/AU2010273938A1/en not_active Abandoned
- 2010-07-19 EP EP10800657A patent/EP2454388A2/en not_active Withdrawn
- 2010-07-19 CA CA2768475A patent/CA2768475A1/en not_active Abandoned
- 2010-07-19 US US13/384,567 patent/US20120289416A1/en not_active Abandoned
-
2012
- 2012-01-16 IL IL217565A patent/IL217565A0/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070083334A1 (en) * | 2001-09-14 | 2007-04-12 | Compugen Ltd. | Methods and systems for annotating biomolecular sequences |
US20060234347A1 (en) * | 2005-04-13 | 2006-10-19 | Harding Thomas C | Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
WO2008118877A2 (en) * | 2007-03-23 | 2008-10-02 | The Translational Genomics Research Institute | Method of diagnosing, classifying and treating endometrial cancer and precancer |
US20090192133A1 (en) * | 2008-01-08 | 2009-07-30 | Horton William A | Treatment for achondroplasia |
Non-Patent Citations (2)
Title |
---|
BYRON ET AL.: "FGFR2 as a molecular target in endometrial cancer.", FUTURE ONCOL, vol. 5, no. 1, February 2009 (2009-02-01), pages 27 - 32, XP009165280, DOI: doi:10.2217/14796694.5.1.27 * |
TALANOW.: "Cancer staging software: A free and web-based cancer staging program and cancer staging tool.", 9 December 2007 (2007-12-09), Retrieved from the Internet <URL:http://web.archive.org/web/20071209083056/http://www.cancerstaging.info> * |
Also Published As
Publication number | Publication date |
---|---|
EP2454388A2 (en) | 2012-05-23 |
US20120289416A1 (en) | 2012-11-15 |
KR20120089838A (en) | 2012-08-14 |
WO2011009114A2 (en) | 2011-01-20 |
AU2010273938A1 (en) | 2012-03-08 |
IL217565A0 (en) | 2012-02-29 |
CA2768475A1 (en) | 2011-01-20 |
JP2013507904A (en) | 2013-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010009337A3 (en) | Signatures and pcdeterminants associated with prostate cancer and methods of use thereof | |
EP4219765A3 (en) | Prostate cancer prognosis using biomarkers | |
WO2009037572A3 (en) | Biomarker combinations for colorectal cancer | |
WO2012006447A3 (en) | Gene signatures for cancer prognosis | |
WO2012047618A3 (en) | Mesothelioma biomarkers and uses thereof | |
WO2007082154A3 (en) | B7-h1 and b7-h4 in cancer | |
WO2008061104A3 (en) | Methods and kits for detecting prostate cancer biomarkers | |
WO2008097908A3 (en) | Methods of diagnosing and prognosing lung cancer | |
EP2061899A4 (en) | Biomarkers for prostate cancer and methods using the same | |
WO2009154952A3 (en) | Systems and methods for determining two or more characteristics of a wafer | |
WO2009036427A3 (en) | Prostate cancer biomarkers | |
EP2457092A4 (en) | Cancer biomarker and the use thereof | |
WO2010009171A3 (en) | Src activation for determining cancer prognosis and as a target for cancer therapy | |
MX2007013727A (en) | Characterizing prostate cancer . | |
WO2013124738A3 (en) | Methods and biomarkers for detection and prognosis of cervical cancer | |
WO2010053816A3 (en) | Biomarkers for diagnosis of breast cancer | |
WO2011009114A3 (en) | Methods and kits used in assessing cancer risk | |
AU324311S (en) | Tongs | |
WO2009047532A3 (en) | Cancer susceptibility loci | |
WO2010017461A3 (en) | Gene methylation in cancer diagnosis | |
WO2015107430A3 (en) | Methods and biomarkers for detection and prognosis of cervical cancer | |
AU320630S (en) | Tyre | |
WO2008030559A3 (en) | Methods, compositions, and kits for the detection and monitoring of colon cancer | |
EP2436763A4 (en) | Method for assessing lymph node metastasis of cancer or the risk thereof, and rapid assessment kit for said method | |
WO2007130726A3 (en) | Methods for the detection of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10800657 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 217565 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012520834 Country of ref document: JP Ref document number: 2768475 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010273938 Country of ref document: AU Ref document number: 370/MUMNP/2012 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 20127004297 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010800657 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2010273938 Country of ref document: AU Date of ref document: 20100719 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13384567 Country of ref document: US |